|

Hypogastric Plexus Block and Ganglion Impar Block for Cervical and Endometrial Cancer Pain Management

RECRUITINGN/ASponsored by University of Brawijaya
Actively Recruiting
PhaseN/A
SponsorUniversity of Brawijaya
Started2024-07-23
Est. completion2025-09-30
Eligibility
Age18 Years+
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05427058

Summary

This study compared the efficacy and safety of superior hypogastric plexus block and ganglion impar block procedures on the management of pelvic and perineal cancer pain in patients with cervical and endometrial cancer

Eligibility

Age: 18 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Unbearable cancer pain that is resistant to WHO (World Health Organization) pain ladder at least 2 weeks medication
* The patient is tired of taking medication orally or complications of current medication (respiratory depression, nausea, vomiting, opioid-induced constipation, gastrointestinal disturbances)
* Patients with pelvic floor pain diagnosed by a (Fellow of Interventional Pain Practice) FIPP-certified pain specialist
* Patients with pain in the perineum diagnosed by a FIPP-certified pain specialist
* Numerical Rating Scale \>4
* \>18 years old
* Able and willing to sign an informed consent

Exclusion Criteria:

* Refuse to be included in the research
* Blood clotting disorders (including taking anticoagulant drugs)
* Local infection in the area of action
* Loss to follow up

Drop-out Criteria:

* Loss to follow up
* Intervention complications occur
* Failed intervention

Conditions3

CancerCervical CancerEndometrial Cancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.